APA (7th ed.) Citation

Codenotti, S., Asperti, M., Poli, M., Lorenzi, L., Pietrantoni, A., Cassandri, M., . . . Fanzani, A. (2025). Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization. Molecular Metabolism, 92(102085-), . https://doi.org/10.1016/j.molmet.2024.102085

Chicago Style (17th ed.) Citation

Codenotti, Silvia, Michela Asperti, Maura Poli, Luisa Lorenzi, Alberto Pietrantoni, Matteo Cassandri, Francesco Marampon, and Alessandro Fanzani. "Synthetic Inhibition of SREBP2 and the Mevalonate Pathway Blocks Rhabdomyosarcoma Tumor Growth in Vitro and in Vivo and Promotes Chemosensitization." Molecular Metabolism 92, no. 102085- (2025). https://doi.org/10.1016/j.molmet.2024.102085.

MLA (9th ed.) Citation

Codenotti, Silvia, et al. "Synthetic Inhibition of SREBP2 and the Mevalonate Pathway Blocks Rhabdomyosarcoma Tumor Growth in Vitro and in Vivo and Promotes Chemosensitization." Molecular Metabolism, vol. 92, no. 102085-, 2025, https://doi.org/10.1016/j.molmet.2024.102085.